 |
||||||||||||
|
Event Listings
As the cell immunotherapy field continues to explode beyond the well-hyped CAR-Ts, the Innate Killer Summit 2018 gathers the leading scientific and business experts from all the key stakeholders to identify future approaches to deliver commercially viable off-the-shelf therapies. By harnessing the unique power of the innate immune system, seize the enhanced drug development opportunity of NK cell immunotherapies. Capitalize on a more robust allogeneic development approach that overcomes common safety concerns experienced by other cell therapies. The 3rd Innate Killer Summit offers the platform for experts and leaders in the Innate Killer Community to come together, network and create collaborative partnerships. Learn from case studies on: Increasing Persistency and Specificity with CAR-NK – novel clinical data outlining methods to redirect NK cell specificity and in vivo persistence Combination Therapies to Support and Enhance Immunotherapeutic Response – explore the use of targeted antibodies and cytokines to work alongside NK cells to improve their role in persistence and anti-tumor effects Off-the-Shelf Allogeneic Therapies to Improve Accessibility of Treatment – utilize the capability of administering NK therapies as an “Off-the-Shelf” living drug Manufacturing Considerations to Improve Proliferation in NK Clinical Trials – create solutions to manufacturing hurdles specifically in regards to scaling up, expansion and increasing NK proliferative capabilities Regulatory Outline to Ensure Safety and Efficacy in NK Clinical Trials – identify the regulatory framework and procedures that surround NK research area Urls: Brochure: https://go.evvnt.com/173476-1 Website: https://go.evvnt.com/173476-2 Prices: Gold: Conference and 2 Workshops: USD 2397 Silver: Conference and 1 Workshop: USD 2098 Bronze: Conference Only: USD 1599 Workshop Only: USD 499 Speakers: Jeffrey Miller, Professor of Medicine, University of Minnesota, Wilfred Germeraad, Chief Scientific Officer, Chief Operating Officer and Co-Founder, Cimaas, Katy Rezvani, Chief, Section of Cellular Therapy at Department of Stem Cell Transplantation and Cellular Therapy MD Anderson, Cancer Center, Michael Caligiuri, Director of the Comprehensive Cancer Center CEO, James Cancer Hospital and Solove Research Institute, Ohio State University, Bob Valamehr, Vice President, Cancer Immunotherapy and Reprogramming Biology, Fate Therapeutics, Karl-Johan Malmberg, Professor of Immunology, University of Oslo, Joachim Koch Professor of Biochemistry, Goethe-University Frankfurt and Research Program Head Affimed, Mark Lowdell, Professor, Cell and Tissue Therapy, University College London, Sang Hoon Paik, General Manager / Head of Process Unit, Greencross, Nicholas Huntington, Molecular Immunology Laboratory Head, Walter and Eliza Hall Institute of Medical Research, Jan Spanholtz, Chief Scientific Officer and Research and Development Manager, Glycostem Therapeutics, Dan Kaufman, Professor of Medicine and Director of Cell Therapy, University of California, Sandip Patel, Assistant Professor, Medical Oncology/Hematology, UC San Diego Moores Cancer Center, Robin Pariha, r Assistant Professor, Center for Cell and Gene Therapy, Baylor College of Medicine, Eugene Zhukovsky, Chief Scientific Officer, Biomunex Pharmaceuticals, Katharine Hsu, Attending Physician and Member, Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, Raymond Urbanski, Chief Medical Officer, GT Biopharma, Steve Doberstein, Chief Scientific Office and Senior Vice President of Research, Nektar Therapeutics
Registration Website: http://go.evvnt.com/173476-0 Submitted by Love Evvnt, Evvnt on Tuesday, 27 March 2018 at 8:00 AM Category: Health Care & Medical |
||||||||||||
|
|
||||||||||||
 |
||||||||||||
|
Scoopasia v1.0b. Copyright © 2018
Today is Monday, 25 June 2018 |
||||||||||||
Want to get your press releases, event listings, and job ads on Scoopasia? 
| Journalist's Toolbox |  |
|
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!
(Instant Information Request) The easiest way to ask questions and request information from the PR community. Drill down, dig deep, for media information the way you want it. Resources and tools you can't do without. | |
| PR Tools |
|
Scoopasia Blog Search
Search the largest handpicked collection of Asia's most prominent and influential blogs. |
| Resources |
|
More Coming Soon... |
| Latest Jobs |
| Sorry, there are currently no entries posted here. |
